Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New shingles drug aims to cut pain faster and prevent lingering nerve damage

NCT ID NCT07099157

First seen Jan 05, 2026 · Last updated May 23, 2026 · Updated 26 times

Summary

This study compares two antiviral drugs, brivudine and famciclovir, in 140 adults with shingles. The main goal is to see which one reduces pain more effectively after 30 days. Researchers will also check how quickly skin lesions heal and whether long-term nerve pain (postherpetic neuralgia) is prevented. Participants take one pill daily for 7 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HERPES ZOSTER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

    RECRUITING

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Peking University First Hospital

    RECRUITING

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Peking University Third Hospital

    RECRUITING

    Beijing, 100191, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xuanwu Hospital, Capital Medical University

    NOT_YET_RECRUITING

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.